
NeuBase Therapeutics, Inc.
USD0.38
-0.01 (-1.56%)
CEO
Todd P. Branning
IPO Date
2004-05-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.38
Prev. Close
$0.38
Day Low
$0.36
Day High
$0.39
52W Low
$0.36
52W High
$4.44
Market Cap
$0.00B
Volume
0.09M
| 12 Aug 2022 |
| Chardan Capital |
| Buy |
| Buy |
| maintain |
| 31 May 2022 | HC Wainwright & Co. | Buy | Buy | maintain |
| 13 May 2022 | Chardan Capital | Buy | Buy | maintain |
| 1 Jun 2021 | HC Wainwright & Co. | Buy | Buy | maintain |
| 12 Feb 2021 | HC Wainwright & Co. | Buy | Buy | maintain |
| 16 Jun 2020 | RBC Capital | Outperform | Outperform | maintain |
| 1 Apr 2020 | Chardan Capital | Buy | Buy | maintain |